Growth Metrics

Family Office Of America (FOFA) Net Cash Flow Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Family Office Of America - - 783,126.00 -66.02%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -66.02%
Dec 31, 2025 -235.77%
Sep 30, 2025 1,591.05%
Jun 30, 2025 172.61%
Mar 31, 2025 525.86%
Dec 31, 2024 -313.87%
Sep 30, 2024 30.24%
Jun 30, 2024 -424.04%
Mar 31, 2024 263.97%
Dec 31, 2023 92.16%
Sep 30, 2023 84.91%
Jun 30, 2023 104.95%
Mar 31, 2023 58.59%
Dec 31, 2022 41.87%
Sep 30, 2022 56.89%